Conference Coverage

VTE risk after bariatric surgery should be assessed


 

REPORTING FROM SAGES 2018


When patients test hypercoagulable at baseline, “we are [now] leaning towards [enoxaparin] 60 mg twice daily,” he said.

Ultimately, anticoagulation TEM could be used to titrate patients into the normal range. For best outcomes, it’s likely that “obese patients require goal-directed therapy instead of weight-based or fixed dosing,” he said, but nothing is going to happen until insurance steps up.

The patients did not have underlying coagulopathies, and 33 (82.5%) were women; the average age was 44 years and average body mass index was 43.6 kg/m2. The mean preop Caprini score was 4, indicating moderate VTE risk. Surgery lasted about 200 minutes. Patients were out of bed and walking on postop day 0.

The investigators had no relevant disclosures.

SOURCE: Urias D et al. World Congress of Endoscopic Surgery hosted by SAGES & CAGS abstract S023.

Pages

Recommended Reading

Weight recidivism after bariatric surgery: What constitutes failure?
MDedge Cardiology
Seven years after bariatric surgery, more than 40% still off insulin
MDedge Cardiology
No benefit found in pre-bariatric surgery weight loss programs
MDedge Cardiology
Chronicity of obesity provides rationale for physician-surgeon collaboration
MDedge Cardiology
Psych evaluation identifies bariatric surgery patients who do less well
MDedge Cardiology
Large database analysis suggests safety of bariatric surgery in seniors
MDedge Cardiology
Metabolic and bariatric surgery reduces CVD risk in severely obese adolescents
MDedge Cardiology
Bariatric surgery comes with some risk of complications
MDedge Cardiology
Gastric bypass T2D benefit can fade over time
MDedge Cardiology
Pre–bariatric surgery weight loss improves outcomes
MDedge Cardiology